Evaluation of metabolic syndrome in adults of Talca city, Chile

Nutrition Journal

Volumn 7, Issue 1, 2008, Pages

  Mujica, Veronica ^a,b   Leiva, Elba ^b   Icaza, Gloria ^b   Diaz, Nora ^b   Arredondo, Miguel ^c   Moore Carrasco, Rodrigo ^b   Orrego, Roxana ^b   Vásquez, Marcela ^b   Palomo, Ivan ^b  

^a Maule Health Service   (Chile)

^b UNIVERSIDAD DE TALCA   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; LIPID;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILE; CLINICAL EVALUATION; DISEASE CLASSIFICATION; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PROBABILITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; AGE; BLOOD; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; SEX FACTORS; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 44349098089     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-7-14     Document Type: Article

References (43)

1. NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III Participants Age 50 Years and Older. CM Alexander PB Landsman SM Teutsch SM Haffner, Diabetes 2003 52 1210 14 10.2337/diabetes.52.5.1210 12716754
2. Insulin resistance, cardiovascular disease and the metabolic syndrome: how well do the emperor's clothes fit? GM Reaven, Diabetes Care 2004 27 1011 1012 10.2337/diacare.27.4.1011 15047666
3. Contributions of Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose. MA Abdul-Ghani D Tripathy RA De Fronzo, Diabetes Care 2006 29 1130 1139 10.2337/dc05-2179 16644654
4. Variations in insulin stimulated glucose uptake in healthy individuals with glucose intolerance. C Hollenbeck GM Reaven, J Clin Endocrinol Metab 1987 64 1169 73 3553221
5. Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. B Isomaa P Almgren T Tuomi B Forsén K Lahti M Nissén MR Taskinen L Groop, Diabetes Care 2001 24 683 89 10.2337/diacare.24.4.683 11315831
6. Metabolic Syndrome and Its Impact on Cardiovascular Disease Incident, the San Antonio Heart Study. C Lorenzo K Williams KJ Hunt SM Haffner, Diabetes Care 2006 29 625 630 10.2337/diacare.29.03.06.dc05-1755 16505517
7. Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population: The Bruneck Study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger JB Meigs RC Bonadonna M Muggeo, Diabetes Care 2007 30 318 324 10.2337/dc06-0919 17259501
8. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. AJ Hanley K Williams MP Stern SM Haffner, Diabetes Care 2002 25 1177 1184 10.2337/diacare.25.7.1177 12087016
9. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. DR Mathews JP Hosker AS Rudensky BA Taylor DF Treacher, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825
10. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
11. Rol of insulin resistance in human disease. G Reaven, Diabetes 1988 37 1595 1607 10.2337/diabetes.37.12.1595 3056758
12. Critical evaluation of the Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Y Liao S Kwon S Shaughnessy P Wallace A Hutto A Jenkins R Klein WT Garvey, Diabetes Care 2004 27 978 983 10.2337/diacare.27.4.978 15047659
13. Definition, diagnosis and classification of diabetes mellitus and its complication. WHO consultation, WHO/NCD/99.2 31 33
14. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and treatment of High Cholesterol. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
15. Body mass index and percent body fat: a meta analysis among different ethnic groups. P Deurenberg M Yap WA van Staveren, Int J Obes Relat Metab Disord 1998 22 1164 1171 10.1038/sj/ijo/0800741 9877251
16. Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. LP Palaniappan MR Carnethon SP Fortmann, Diabetes Care 2002 25 1351 1357 10.2337/diacare.25.8.1351 12145234
17. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. J Liu AJ Hanley TK Young SB Harris B Zinman, Int J Obes (Lond) 2006 30 669 676 10.1038/sj.ijo.0803179 16302011
18. Body size, body composition, and fat distribution: a comparison of young New Zealand men of European, Pacific Island, and Asian Indian ethnicities. E Rush L Plank V Chandu M Laulu D Simmons B Swinburn C Yajnik, N Z Med J 2004 117 U1203 15608799
19. Abdominal obesity and metabolic syndrome. JP Despres I Lemieux, Nature 2006 444 881 887 10.1038/nature05488 17167477
20. New criteria for "obesity disease" in Japan. Examination Committee of Criteria for "Obesity Disease" in Japan, the Japan Society for the Study of Obesity, Circ J 2002 66 987 992 10.1253/circj.66.987 12419927
21. IDF Epidemiology Task Force Consensus Group: The metabolic syndrome -a worldwide definition. KG Alberti P Zimmet J Shaw, Lancet 2005 366 1059 1062 10.1016/S0140-6736(05)67402-8 16182882
22. The Importance of Waist Circumference in the Definition of Metabolic Syndrome: Prospective analyses of mortality in men. PT Katzmarzyk I Janssen R Ross TS Church SN Blair, Diabetes Care 2006 29 2 404 409 10.2337/diacare.29.02. 06.dc05-1636 16443895
23. Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion. JE Shaw PZ Zimmet KG Alberti, Diabetes Care 2006 29 5 1170 1172 10.2337/dc06-0013 16644659
24. The American Heart Association, National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. SM Grundy HB Brewer Jr JI Cleeman SC Smith C Lenfant, Circulation 2005 112 e285 90 10.1161/CIRCULATIONAHA.105.169405
25. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. MK Rutter JB Meigs LM Sullivan RB D'Agostino PW Wilson, Diabetes 2005 54 3252 3257 10.2337/diabetes.54.11.3252 16249452
26. El síndrome metabólico como factor de riesgo cardiovascular. A Grima M León B Ordõez, Rev Esp Cardiol Supl 2005 5 16D 20D 10.1157/13083444
27. Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin. J Sierra-Johnson BD Johnson TG Allison KR Bailey GL Schwartz ST Turner, Diabetes Care 2006 29 668 672 10.2337/diacare.29.03.06. dc05-0970 16505524
28. Encuesta Nacional de Salud 2003. Ministerio de Salud de Chile, Departamento de Salud Pública de la Pontificia Universidad Católica de Chile: Informe Técnico 2003
29. Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile 2005. I Palomo G Icaza V Mujica E Leiva M Vásquez M Alarcón, Rev Med Chile 2007 135 904 912 17914548
30. Muestreo de encuesta. L Kish, México: Trillas 1972
31. With or without a gold standard. R Pfeiffer P Castle, Epidemiology 2005 16 5 595 95 10.1097/01.ede.0000173328.31497.ec 16135933
32. Generalized additive models for medical research. T Hastie R Tibshirani, Statistical Methods in Medical Research 1995 4 187 196 10.1177/ 096228029500400302 8548102
33. Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. HS Park SY Lee SM Kim JH Han DJ Kim, Diabetes Care 2006 29 933 934 10.2337/diacare.29.04.06.dc06-0069 16567843
34. Prevalence of the Metabolic Syndrome in Southwest Germany. BO Boehm S Claudi-Boehm S Yildirim, Scand J Clin Lab Invest Suppl 2005 240 122 128 10.1080/00365510500236309 16112969
35. Prevalence of the Metabolic Syndrome Among US Adults Findings From the Third National Health and Nutrition Examination Survey. ES Ford WH Giles WH Dietz, JAMA 2002 287 356 359 10.1001/jama.287.3.356 11790215
36. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. CC Tanchoco AJ Cruz CA Duante AD Litonjua, Asia Pac J Clin Nutr 2003 12 3 271 6 14505989
37. Prevalencia de Síndrome Metabólico. A Cordero E Alegría M Leon, Rev Esp Cardiol 2006 5 11 15 10.1157/13083443
38. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. F Azizi P Salehi A Etemadi S Zahedi-Asl, Diabetes Res Clin Pract 2003 61 29 37 10.1016/S0168-8227(03)00066-4 12849921
39. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP criteria. A Ramachandran C Snehalatha K Satyavani S Sivasankari V Vijay, Diabetes Res Clin Pract 2003 60 199 204 10.1016/S0168-8227(03)00060-3 12757982
40. The prevalence of Metabolic Syndrome in middle-aged in Kaunas population. O Gustiene R Slapikas J Klumbiene G Sakalauskiene R Kubilius S Bagdzeviciûte R Zaliûnas, Medicine Kaunas 2005 41 10 867 76
41. Metabolic syndrome in young adults from two socioeconomic Latin American settings. P Bustos A Da Silva H Amigo H Bettiol M Barbieri, Nutr Metab Cardiovasc Dis 2007 17 581 9 10.1016/j.numecd.2006.06.001 16895751
42. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. R Miccoli C Bianchi L Odoguardi G Penno F Caricato, Nutr Metab Cardiovasc Dis 2005 15 4 250 4 10.1016/j.numecd.2004.09.002 16054548
43. Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes. G De Simone RB Devereux M Chinali, Diabetes Care 2007 30 7 1851 56 10.2337/dc06-2152 17440172